+30 year(s) experience
Deborah Writes For
A rise in bureaucracy and increased liability for clinical trial sponsors have impacted the popularity of India as a location for pharmaceutical companies’ clinical studies.
Topic Clinical trials
The expectations and goals for treating epilepsy have recently been reset to a higher bar due to a number of new drug treatments entering the market